ZIMBYS Trademark

Trademark Overview

On Wednesday, April 27, 2011, a trademark application was filed for ZIMBYS with the United States Patent and Trademark Office. The USPTO has given the ZIMBYS trademark a serial number of 79097878. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, April 27, 2021. This trademark is owned by NOVARTIS AG. The ZIMBYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of disorders and diseases of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of bacteria-based diseases and disorders, auto-immune diseases and disorders, renal diseases and disorders, diabetes; anti-infective preparations, antiviral preparations, antibiotics and antifungal preparations
zimbys

General Information

Serial Number79097878
Word MarkZIMBYS
Filing DateWednesday, April 27, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, April 27, 2021
Registration Number4137443
Registration DateTuesday, May 8, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of disorders and diseases of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of bacteria-based diseases and disorders, auto-immune diseases and disorders, renal diseases and disorders, diabetes; anti-infective preparations, antiviral preparations, antibiotics and antifungal preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Monday, November 22, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, November 22, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, November 30, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 4, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 4, 2019INVALIDATION PROCESSED
Wednesday, August 14, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 14, 2018CANCELLED SECTION 71
Monday, May 8, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 4, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, January 24, 2013FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 24, 2013FINAL DISPOSITION PROCESSED
Sunday, November 25, 2012NOTIFICATION PROCESSED BY IB
Wednesday, August 8, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 8, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, February 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 8, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 18, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 17, 2012ASSIGNED TO LIE
Wednesday, December 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 24, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 24, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 26, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 26, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 25, 2011REFUSAL PROCESSED BY IB
Thursday, July 7, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 7, 2011REFUSAL PROCESSED BY MPU
Thursday, July 7, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 6, 2011NON-FINAL ACTION WRITTEN
Wednesday, July 6, 2011ASSIGNED TO EXAMINER
Friday, July 1, 2011APPLICATION FILING RECEIPT MAILED
Monday, June 27, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 24, 2011LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 23, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zimbys system disorders preparations diseases treatment pharmaceutical prevention immune based bacteria